MedPath

PACLITAXEL INJECTION, USP

PACLITAXEL INJECTION, USP

Discontinued
DIN Number

02408074

Drug Class

Human

Market Date

N/A

Company
HC

Mylan Pharmaceuticals ULC

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02408074
AIG Number0124214001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01CD01 PACLITAXEL
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

PACLITAXELActive
Strength: 6 MG / ML
Monograph: PACLITAXEL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.